Home › Funds › Knoll Capital Management, LLC › BHVN
Knoll Capital Management, LLC position in BHVN
BIOHAVEN LTD · Health Care
Knoll Capital Management, LLC reported holding 2,352,520 shares of BHVN (BIOHAVEN LTD) in its Q2 2026 13F filing — a position valued at US$35.0M, representing 16.33% of its reported portfolio and ranking #1 among its reported holdings. Knoll Capital Management, LLC has disclosed BHVN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Knoll Capital Management, LLC's BHVN position evolved
Knoll Capital Management, LLC first disclosed a stake in BHVN in Q3 2023 at 490,422 shares (US$12.8M). The position peaked in Q3 2024 at 710,422 shares, worth US$35.5M. Across 12 filings, Knoll Capital Management, LLC increased the stake 6 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 2,352,520 shares valued at US$35.0M — an increase of 23,918 shares quarter over quarter.. Notable position changes include a 45% increase in Q2 2024 (shares rose 44% over the following quarter), a 160% increase in Q4 2025 (shares fell 25% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 490.42K | $12.76M | New |
| Q4 2023 | 490.42K | $20.99M | Hold |
| Q1 2024 | 490.42K | $26.82M | Hold |
| Q2 2024 | 710.42K | $24.66M | Add |
| Q3 2024 | 710.42K | $35.50M | Hold |
| Q4 2024 | 760.42K | $28.40M | Add |
| Q1 2025 | 830.88K | $19.97M | Add |
| Q2 2025 | 895.27K | $12.63M | Add |
| Q3 2025 | 895.27K | $13.44M | Hold |
| Q4 2025 | 2.33M | $26.29M | Add |
| Q1 2026 | 2.33M | $19.70M | Hold |
| Q2 2026 | 2.35M | $35.01M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BHVN and 13F data
BHVN (BIOHAVEN LTD) is a Health Care company. 29 other funds we track also report a position in BHVN — the largest reported positions include MONTANOVA CAPITAL, LLC (US$153.1M), INFINITUM ASSET MANAGEMENT, LLC (US$93.0M), Royalty Pharma Sub-Manager, LLC (US$43.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BHVN
- MONTANOVA CAPITAL, LLC 10.29M sh · $153.07M · Q2 2026
- INFINITUM ASSET MANAGEMENT, LLC 6.25M sh · $93.00M · Q2 2026
- Royalty Pharma Sub-Manager, LLC 2.94M sh · $43.70M · Q2 2026
- Cormorant Asset Management, LP 2.61M sh · $38.84M · Q2 2026
- TCG Crossover Management, LLC 1.78M sh · $26.49M · Q2 2026
- ARS Investment Partners, LLC 1.37M sh · $20.45M · Q2 2026
More on Knoll Capital Management, LLC
FAQ
How long has Knoll Capital Management, LLC held BHVN?
Knoll Capital Management, LLC has disclosed BHVN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Knoll Capital Management, LLC's current position in BHVN?
As of Q2 2026, Knoll Capital Management, LLC holds 2.35M shares of BHVN (BIOHAVEN LTD), valued at $35.01M, representing 16.33% of its reported portfolio and ranking #1.
Has Knoll Capital Management, LLC been buying or selling BHVN?
In the latest 13F filing (Q2 2026), Knoll Capital Management, LLC increased its position in BHVN. The position peaked in Q3 2024 at 710.42K shares.
Which other funds hold BHVN?
Other major institutional holders of BHVN include MONTANOVA CAPITAL, LLC, INFINITUM ASSET MANAGEMENT, LLC, Royalty Pharma Sub-Manager, LLC, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.